Nouveau Life Pharmaceuticals
(OTC) NOUV
Nouveau Life Pharmaceuticals Financials at a Glance
Market Cap
$666,100
Revenue (TTM)
$0.00
Net Income (TTM)
$153.38K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
82.51 (High)
Dividend
$0.00
Beta (Volatility)
82.51 (High)
Price
$0.00
Volume
400,000
Open
$0.00
Price
$0.00
Volume
400,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
82.51 (High)
Price
$0.00
Volume
400,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
NOUV News
NOUV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nouveau Life Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Sang Tae Choi
Website
www.nouv-info.comHeadquarters
Ft. Lauderdale, FL 33301, US
NOUV Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-3%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$666.10K
Shares Outstanding
6.66B
Volume
400.00K
Short Interest
0.00%
Avg. Volume
634.55K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$17.21K
EBITDA
$17.21K
Operating Cash Flow
$22.91K
Capital Expenditure
$0.00
Free Cash Flow
$22.91K
Cash & ST Invst.
$3.96K
Total Debt
$67.77K
Nouveau Life Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$666.10K
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$5.62K
+95.0%
EBITDA
$5.62K
+92.1%
Quarterly Fundamentals
Net Cash
$7.71K
+112.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.29%
N/A
Return on Invested Capital
-3.14%
N/A
Free Cash Flow
$3.42K
+244.2%
Operating Cash Flow
$3.42K
+244.2%